| Effect | Decrease |
| Trial Design | Double blind |
| Trial Length | 6+ Months |
| Number of Subjects | 21 |
| Sex | n/a |
| Age Range | 30-44, 45-64 |
Curcuminoids, at three daily doses of 250mg, is associated with lessening the oxidative damage in beta-thalassemia/Hb E patients. Glutathione peroxidase and superoxide dismutase were both increased in the red blood cells of patients given curcumin.
